Vepacel
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture)
- Made by
- Ology Bioservices Ireland LTD
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Active immunisation against H5N1 subtype of influenza A virus. This indication is based on immunogenicity data from subjects from the age of 6 months onwards following administration of two doses of vaccine prepared with H5N1 subtype strains. Vepacel should be used in accordance with Official guidance.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Ology Bioservices Ireland LTD |
|---|---|
| Active substance | Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BB01 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2012-02-17 |
| Last updated by the regulator | 2020-10-28 |
| EMA product number | EMEA/H/C/002089 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).